2025 annual financial data
Revelation Biosciences 2025 Operating margin
Revelation Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -9,070,814 USD and net income was -8,913,649 USD.
Operating cash flow was -8,269,581 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,070,814 USD
- Net income
- -8,913,649 USD
- Operating cash flow
- -8,269,581 USD